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Abstract
Whilst women frequently visit general practitioners for help with menopausal symptoms such as hot flushes, research shows many 
women also self-prescribe complementary and alternative medicine (CAM) to control these symptoms. Further research is required to 
understand women’s motivations for self-prescribing CAM during menopause and to inform safe usage if these CAM and hormone 
products are utilised concurrently. 
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Every woman will go through menopause. Whilst 
women frequently visit general practitioners (GPs) 
for help with menopausal symptoms, and hormone 
replacement therapy (HRT) is the most common 
treatment prescribed1, research shows menopausal 
women are also frequent users of complementary and 
alternative medicine (CAM), often without the guidance 
of a CAM practitioner.2 Concerns have been raised that 
self-prescribed CAM products may have troubling side 
effects and may interact with hormone products.3 
There may be several reasons that women self-
prescribe CAM alongside conventional HRT treatment. 
For example, the belief that CAM is inherently safe may 
lead menopausal women to consider there is no harm in 
self-prescribing these products alongside conventional 
medications such as HRT. This belief may be strengthened 
by the fact that most CAM products are not of a synthetic 
nature4 and CAM products can be easily accessed in retail 
stores such as pharmacies, supermarkets and health food 
shops without any limitations.5 Furthermore, research 
has shown some menopausal women make treatment 
decisions (including CAM) exclusively by themselves.6,7 
They may consider their health is their own responsibility, 
especially those who are long-term users of CAM 
products.8 Menopausal women may also perceive there 
is no need to talk about their ‘safe’ CAM use when GPs 
prescribe HRT for their symptoms. Meanwhile, research 
has shown that some GPs hold negative attitudes towards 
the use of CAM in menopause care7, which may make 
it more difficult for menopausal women to discuss their 
use of CAM with them. Cost is another possible reason 
that menopausal women may self-prescribe CAM. Visits 
to GPs and medical specialists are covered or subsidised 
by Australian Medicare9 while only a few types of CAM 
consultations are eligible for private health insurance 
rebates10, making visits to CAM practitioners more 
expensive. Since CAM products are generally believed 
to be safe, menopausal women might seek information 
regarding CAM use from a number of unprofessional 
sources and counterbalance their overall medicine cost 
by ceasing consultations with CAM practitioners.11
Currently, there is a lack of high quality information 
regarding side effects and interactions between HRT and 
commonly used CAM products. However, the possible 
risks in relation to the concurrent use of CAM and HRT 
without professional advice strongly highlight the need 
of further multi-method studies. Conventional and CAM 
health care providers need to be aware of menopausal 
women’s perceptions, their reasons for their choice of 
therapy, and their expectations of CAM practitioners (i.e. 
naturopaths, Chinese herbal medicine practitioners and 
acupuncturists) for symptom relief. It is important that 
further investigations provide details of the health-seeking 
behaviour, decision-making progress, and information 
sources of menopause women who take HRT and also 
utilise self-prescribed CAM. In addition, the concurrent 
utilisation of self-prescribed CAM and professional-
prescribed HRT suggests a significant opportunity for 
GPs, gynaecologists and/or endocrinologists to take 
a more active role in guiding menopause care. It is an 
imperative for conventional medical practitioners to 
initiate conversations with menopausal women about 
their CAM use during routine visits, advise these women 
to be cautious about CAM-HRT polypharmacy, and 
refer these women to a qualified CAM practitioner for 
safety advice if necessary.12 Due to the broad diversity 
of CAM products and practices, in order to achieve 
optimal menopause care, these conventional medical 
Australian Journal of Herbal Medicine 2016 28(3) 
74© NHAA 2016
Commentary
practitioners may need to acquire sufficient knowledge of 
CAM through attending CAM workshops or training and 
cooperating with CAM practitioners.13
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